EP Patent

EP3704101A1 — Cocrystals, pharmaceutical compositions thereof, and methods of treatment involving same

Assigned to Les Laboratoires Servier SAS · Expires 2020-09-09 · 6y expired

What this patent protects

Provided are solid forms of a compound useful for treating cancer, pharmaceutical compositions thereof, and methods of treating cancer comprising administering the solid forms described herein to a patient in need thereof.

USPTO Abstract

Provided are solid forms of a compound useful for treating cancer, pharmaceutical compositions thereof, and methods of treating cancer comprising administering the solid forms described herein to a patient in need thereof.

Drugs covered by this patent

Patent Metadata

Patent number
EP3704101A1
Jurisdiction
EP
Classification
—
Expires
2020-09-09
Drug substance claim
No
Drug product claim
No
Assignee
Les Laboratoires Servier SAS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.